DEGs with a False Discovery Rate of < 0.05 by this method were considered significant, and intersected with a curated list of NF-κB regulators and targets to determine the nature and extent of NF-κB deregulation in ccRCC. This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.